Cargando…
The Evolution of Pleconaril: Modified O-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
Coxsackieviruses type B are one of the most common causes of mild upper respiratory and gastrointestinal illnesses. At the time of writing, there are no approved drugs for effective antiviral treatment for Coxsackieviruses type B. We used the core-structure of pleconaril, a well-known antienterovira...
Autores principales: | Volobueva, Alexandrina, Egorova, Anna, Galochkina, Anastasia, Ekins, Sean, Zarubaev, Vladimir, Makarov, Vadim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144106/ https://www.ncbi.nlm.nih.gov/pubmed/32188089 http://dx.doi.org/10.3390/molecules25061345 |
Ejemplares similares
-
Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3
por: Shetnev, Anton A., et al.
Publicado: (2022) -
Miscellaneous Antiviral Agents (Interferons, Imiquimod, Pleconaril)
por: Dolin, Raphael
Publicado: (2015) -
Nancy Spero /
por: Spero, Nancy, 1926-
Publicado: (1996) -
Nancy Mitford : a memoir /
por: Acton, Harold, 1904-1994
Publicado: (1975) -
New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
por: Tănase, Constantin I., et al.
Publicado: (2019)